Home > > > News

New ADHD Medication Shows Positive Results in Testing

A new drug may help reduce symptoms in ADHD children.

Thursday September 18th - 11:14am

Drug company Addrenex Phamaceuticals reported on September 10 that phase 3 clinical testing for a new ADHD medication, called Clonicel, showed significant positive results.

The medication is a version of clonidine, a widely used hypertension drug that diminishes the body's hyper-reactivity to stress. Clonicel targets the body's stress response center, and may be more effective than stimulants in alleviating mood swings and emotional outbursts associated with ADHD.

This was the first study to test a long-acting version of clonidine in ADHD children. The clinical test, on children ages six to 17, found that symptoms were reduced significantly more than with the placebo.

Addrenex is also currently testing a combination treatment of Clonicel with stimulants, to determine if the two treatments together alleviate a broader range of symptoms than either drug alone.

Learn more about the results of the study and Addrenex Phamaceuticals.

What do you think of this article? Share your comments on www.ADDConnect.com, ADDitude's community site. Check out the new ADHD Medication User Reviews and the ADHD Adults Support Group. Your fellow ADDers want to hear from you!

Copyright © 1998 - 2013 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 39 W. 37th Street, 15th Floor, New York, NY 10018